EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nonantibiotic Treatment of Clinical Multidrug‐Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells

Sareh Bagheri-Josheghani iD, Mahmood Saffari, Hamed Mirzaei, Zahra Sadat Fateminasab, Mozhgan Derakhshan-Sefidi, Somaye Rashki, Bita Bakhshi iD

Canadian Journal of Infectious Diseases and Medical Microbiology · 2026-01 · 2026 (1)

DOI: 10.1155/cjid/3465372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Infectious Diseases and Medical Microbiology, online erschienen am 28.05.2026. Verfasst von Sareh Bagheri-Josheghani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran, kaums.ac.ir. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kashan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the antimicrobial potential of the supernatant (conditioned medium) of mesenchymal stem cells–derived conditioned medium (MSCs CM), incorporated in chitosan nanoparticles (CS NPs), against multidrug‐resistant (MDR) clinical isolates. Dynamic light scattering (DLS), zeta potential (ZP), and scanning electron microscopy (SEM) assays were used to characterize CS NPs. MSCs CM was incorporated into CS NPs, and its release pattern from the composite (MSCs CM–CS NPs) was evaluated. Antibacterial properties of MSCs CM–CS NPs, as well as MSCs CM and CS NPs, were assessed by the microbroth dilution technique. The average particle size of most CS NPs was 85.2 nm, and their zeta potential was 32.1 mV. SEM findings supported the morphology of the prepared CS NPs and the synthesized composite (MSCs CM–CS NPs). Entrapment efficiency of the new construct was 71%. The antimicrobial activity of the new construct (MSCs CM–CS NPs: 1000 μg/mL + 0.05%) against MDR bacteria was significantly higher compared with MSCs CM (1000 μg/mL) and CS NPs (0.05%) each alone. This composite exhibited the synergistic antibacterial activity of the combination of MSCs CM and CS NPs, resulting in a more potent dose‐dependent antibacterial activity against MDR clinical isolates.

Schlagwörter

Stichwörter der Autor:innen

antibacterialbacterial infectionsdrug resistancenanotechnologystem cells

Autor:innen und Institutionen

  • Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran, kaums.ac.ir.
  • Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran, kaums.ac.ir.
  • Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran, kaums.ac.ir.
  • Department of Microbiology, Saveh University of Medical Sciences, Saveh, Iran.
  • Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran, kaums.ac.ir.
  • Department of Laboratory Sciences, Sirjan School of Medical Sciences, Sirjan, Iran.

ORCID-Profile: Sareh Bagheri-Josheghani, Bita Bakhshi

Förderung

  • Kashan University of Medical Sciences

Zitieren

APA

Bagheri-Josheghani, S., Saffari, M., Mirzaei, H., Fateminasab, Z. S., Derakhshan-Sefidi, M., Rashki, S., & Bakhshi, B. (2026). Nonantibiotic Treatment of Clinical Multidrug‐Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells. Canadian Journal of Infectious Diseases and Medical Microbiology, 2026(1). https://doi.org/10.1155/cjid/3465372

Vancouver

Bagheri-Josheghani S, Saffari M, Mirzaei H, Fateminasab ZS, Derakhshan-Sefidi M, Rashki S, et al. Nonantibiotic Treatment of Clinical Multidrug‐Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells. Canadian Journal of Infectious Diseases and Medical Microbiology. 2026;2026(1). doi:10.1155/cjid/3465372

BibTeX
@article{BagheriJosheghani2026,
  author = {Bagheri-Josheghani, Sareh and Saffari, Mahmood and Mirzaei, Hamed and Fateminasab, Zahra Sadat and Derakhshan-Sefidi, Mozhgan and Rashki, Somaye and Bakhshi, Bita},
  title = {Nonantibiotic Treatment of Clinical Multidrug‐Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells},
  journal = {Canadian Journal of Infectious Diseases and Medical Microbiology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/cjid/3465372}
}
Kostenlos starten →